Species differences in hepatic biotransformation of the anthelmintic drug flubendazole.

about

Species differences in hepatic biotransformation of the anthelmintic drug flubendazole.

Item

http://www.wikidata.org/entity/Q39018550

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Species differences in hepatic biotransformation of the anthelmintic drug flubendazole.

@en

Species differences in hepatic biotransformation of the anthelmintic drug flubendazole.

@nl

type

Item

label

Species differences in hepatic biotransformation of the anthelmintic drug flubendazole.

@en

Species differences in hepatic biotransformation of the anthelmintic drug flubendazole.

@nl

prefLabel

Species differences in hepatic biotransformation of the anthelmintic drug flubendazole.

@en

Species differences in hepatic biotransformation of the anthelmintic drug flubendazole.

@nl

P1476

Species differences in hepatic biotransformation of the anthelmintic drug flubendazole.

@en

P2093

C Lanusse

http://www.w3.org/2001/XMLSchema#string

C Mackenzie

http://www.w3.org/2001/XMLSchema#string

G Virkel

http://www.w3.org/2001/XMLSchema#string

M L Maté

http://www.w3.org/2001/XMLSchema#string

T Geary

http://www.w3.org/2001/XMLSchema#string

P2860

Determination of flubendazole and its metabolites in eggs and poultry muscle with liquid chromatography-tandem mass spectrometry.

Carbonyl reductase.

Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution.

Alcohol and aldehyde dehydrogenases: retinoid metabolic effects in mouse knockout models

Human carbonyl reduction pathways and a strategy for their study in vitro.

Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily.

Pharmacokinetic comparison of different flubendazole formulations in pigs: A further contribution to its development as a macrofilaricide molecule.

Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily.

Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen.

Clinical pharmacokinetics of anthelmintic drugs.

P304

493-499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVP.12383

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28092103

http://www.w3.org/2001/XMLSchema#string